Literature DB >> 21440507

Tissue destruction and invasion by Entamoeba histolytica.

Katherine S Ralston1, William A Petri.   

Abstract

Entamoeba histolytica is the causative agent of amebiasis, a disease that is a major source of morbidity and mortality in the developing world. The potent cytotoxic activity of the parasite appears to underlie disease pathogenesis, although the mechanism is unknown. Recently, progress has been made in determining that the parasite activates apoptosis in target cells and some putative effectors have been identified. Recent studies have also begun to unravel the host genetic determinants that influence infection outcome. Thus, we are beginning to get a clearer picture of how this parasite manages to infect, invade and ultimately inflict devastating tissue destruction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440507      PMCID: PMC3104091          DOI: 10.1016/j.pt.2011.02.006

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  90 in total

1.  Amoebapores, archaic effector peptides of protozoan origin, are discharged into phagosomes and kill bacteria by permeabilizing their membranes.

Authors:  Jörg Andrä; Rosa Herbst; Matthias Leippe
Journal:  Dev Comp Immunol       Date:  2003-04       Impact factor: 3.636

2.  Entamoeba histolytica cysteine proteinases with interleukin-1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis.

Authors:  Z Zhang; L Wang; K B Seydel; E Li; S Ankri; D Mirelman; S L Stanley
Journal:  Mol Microbiol       Date:  2000-08       Impact factor: 3.501

3.  Amebic liver abscess: a 15-year experience.

Authors:  G Maltz; C M Knauer
Journal:  Am J Gastroenterol       Date:  1991-06       Impact factor: 10.864

4.  Antisense inhibition of expression of cysteine proteinases affects Entamoeba histolytica-induced formation of liver abscess in hamsters.

Authors:  S Ankri; T Stolarsky; R Bracha; F Padilla-Vaca; D Mirelman
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  Molecular changes in Entamoeba histolytica in response to bacteria.

Authors:  A Bhattacharya; M T Anand; J Paul; N Yadav; S Bhattacharya
Journal:  J Eukaryot Microbiol       Date:  1998 Mar-Apr       Impact factor: 3.346

6.  Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.

Authors:  M Leippe; J Andrä; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

Review 7.  Amoebiasis.

Authors:  Samuel L Stanley
Journal:  Lancet       Date:  2003-03-22       Impact factor: 79.321

8.  Interaction of laminin with Entamoeba histolytica cysteine proteinases and its effect on amebic pathogenesis.

Authors:  E Li; W G Yang; T Zhang; S L Stanley
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Calpain-dependent calpastatin cleavage regulates caspase-3 activation during apoptosis of Jurkat T cells induced by Entamoeba histolytica.

Authors:  Kyeong Ah Kim; Young Ah Lee; Myeong Heon Shin
Journal:  Int J Parasitol       Date:  2007-04-06       Impact factor: 3.981

10.  Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children.

Authors:  Priya Duggal; Rashidul Haque; Shantanu Roy; Dinesh Mondal; R Bradley Sack; Barry M Farr; Terri H Beaty; William A Petri
Journal:  J Infect Dis       Date:  2004-01-20       Impact factor: 5.226

View more
  59 in total

Review 1.  Entamoeba histolytica: a snapshot of current research and methods for genetic analysis.

Authors:  Laura Morf; Upinder Singh
Journal:  Curr Opin Microbiol       Date:  2012-06-02       Impact factor: 7.934

Review 2.  Taking a bite: Amoebic trogocytosis in Entamoeba histolytica and beyond.

Authors:  Katherine S Ralston
Journal:  Curr Opin Microbiol       Date:  2015-08-14       Impact factor: 7.934

3.  Silencing the cleavage factor CFIm25 as a new strategy to control Entamoeba histolytica parasite.

Authors:  Juan David Ospina-Villa; Nancy Guillén; Cesar Lopez-Camarillo; Jacqueline Soto-Sanchez; Esther Ramirez-Moreno; Raul Garcia-Vazquez; Carlos A Castañon-Sanchez; Abigail Betanzos; Laurence A Marchat
Journal:  J Microbiol       Date:  2017-09-28       Impact factor: 3.422

Review 4.  Rab GTPases take centre stage in understanding Entamoeba histolytica biology.

Authors:  Kuldeep Verma; Vijay Kumar Srivastava; Sunando Datta
Journal:  Small GTPases       Date:  2018-10-13

5.  Direct and high-throughput assays for human cell killing through trogocytosis by Entamoeba histolytica.

Authors:  Akhila Bettadapur; Katherine S Ralston
Journal:  Mol Biochem Parasitol       Date:  2020-07-17       Impact factor: 1.759

Review 6.  Chew on this: amoebic trogocytosis and host cell killing by Entamoeba histolytica.

Authors:  Katherine S Ralston
Journal:  Trends Parasitol       Date:  2015-06-09

7.  Amebic lung abscess with coexisting lung adenocarcinoma: a unusual case of amebiasis.

Authors:  Hailong Zhu; Xiangyang Min; Shuai Li; Meng Feng; Guofeng Zhang; Xianghua Yi
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

8.  Invadosome-Mediated Human Extracellular Matrix Degradation by Entamoeba histolytica.

Authors:  Muhammad M Hasan; Jose E Teixeira; Christopher D Huston
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

Review 9.  Strategies to discover the structural components of cyst and oocyst walls.

Authors:  John Samuelson; G Guy Bushkin; Aparajita Chatterjee; Phillips W Robbins
Journal:  Eukaryot Cell       Date:  2013-10-04

10.  Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica.

Authors:  Nicole M Mackey-Lawrence; Xiaoti Guo; Daniel E Sturdevant; Kimmo Virtaneva; Matthew M Hernandez; Eric Houpt; Alan Sher; Stephen F Porcella; William A Petri
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.